<<

СПИСОК ЛИТЕРАТУРЫ

1. Беспалов А.Ю., Звартау Э.Э. Нейропсихофармакология антагонистов NMDA- рецепторов. - СПб.: Невский диалект, 2000. - 297 с.

2. Гамбарян П.П., Дукельская Н.М. Крыса. - М., Советская наука.

- 1955. - 253 с.

3. Звартау Э.Э., Медведев И.О. Современные направления фармакотерапии хронических болевых синдромов //Гедеон Рихтер в СНГ. -2001. - № 1

4. Игнатов Ю.Д., Зайцев А.А., Михайлович В.А., Страшнов В.И. Адренергическая аналгезия. - СПб.: АНТ-М, 1994. - 215 с.

5. Крыжановский Г.Н. Общая патофизиология нервной системы: руководство. - М., 1997.-352 с.

6. Кукушкин М. Л., Решетняк В. К. Механизмы возникновения острой боли и хронических болевых синдромов // Materia Medica. - 1997. - № 3 (15). - С.5-21.

7. Кукушкин М. Л. Патофизиологические механизмы болевых синдромов // Боль. -2003.-№ 1.-С. 5-12.

8. Орбели Л.А. Боль и ее физиологические эффекты // Физиологический журнал СССР. 1936. Т. XXI. Вып. 5-6.

9. Петров В.И., Пиотровский Л.Б., Григорьев И.А. Возбуждающие аминокислоты. -Волгоград. - 1997. - 167 с.

10. Филатова Е.Г., Вейн А.М. Фармакология боли. // Русский медицинский журнал. - 1999. -№ 9. - С.410-418.

11. Abbadie С., Taylor В. К., Peterson М. A., Basbaum A. I. Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine // Pain. - 1997. - Vol. 69.- P. 101-110.

12. Abbott F.V., Hong Y., Franklin К. B. The effect of lesions of the dorsolateral funiculus on formalin pain and morphine analgesia: a dose-response analysis // Pain. - 1996.-Vol. 65.- P.17-23.

13. Allen R.M., Dykstra L. A. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats // Psychopharmacology (Berl). - 1999. - Vol. 142.- P.209-214.

14. Andine P., Orwar O., Jacobson I., Sandberg M., Hagberg H.

Changes in extracellular amino acids and spontaneous neuronal activity during ischemia and extended reflow in the CA1 of the rat hippocampus // J. Neurochem. - 1991. - Vol. 57.- P.222-229.

15. Arvidsson U., Riedl M., Chakrabarti S., Lee J. H., Nakano A. H., Dado R. J., Loh H. H., Law P. Y., Wessendorf M. W., Elde R. Distribution and targeting of a mu-opioid receptor (MORI) in brain and spinal cord // J. Neurosci. - 1995. - Vol. 15.- P.3328- 3341.

16. Attal N. Chronic neuropathic pain: mechanisms and treatment // Clin. J. Pain. - 2000. -Vol. 16.-P.S118-S130.

17. Auer R.N., Coulter К. C. The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801 // Acta Neuropathol. (Berl). - 1994.-Vol. 87.- P.1-7.

18. Auer R.N., Coupland S. G., Jason G. W., Archer D. P., Payne J., Belzberg A. J., Ohtaki M.; Tranmer В. I. Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia // Mol. Chem. Neuropathol. - 1996. - Vol. 29,-P.193-210.

19. Authier N., Gillet J. P., Fialip J., Eschalier A., Coudore F. Description of a short-term Taxol-induced nociceptive neuropathy in rats // Brain Res. - 29-12-2000. - Vol. 887.- P.239-249.

20. Bach F.W., Jensen T. S., Kastrup J., Stigsby B., Dejgard A. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy // Pain. - 1990. - Vol. 40.- P.29-34.

21. Back S.K., Sung B., Hong S. K., Na H. S. A mouse model for peripheral neuropathy produced by a partial injury of the nerve supplying the tail 11 Neurosci. Lett. - 12-4- 2002.-Vol. 322.-P.153-156.

22. Backonja M.M., Serra J. Pharmacologic management part 2: lesser-studied neuropathic pain diseases // Pain Med. - 2004. - Vol. 5 Suppl 1.- P.S48-S59.

23. Bantel C., Eisenach J. C., Duflo F., Tobin J. R., Childers S. R. Spinal nerve ligation increases alpha2-adrenergic receptor G-protein coupling in the spinal cord // Brain Res. - 15-3-2005. - Vol. 1038.- P.76-82.

24. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms // Clin. J. Pain. -2000. - Vol. 16.-P.S12-S20.

25. Behbehani M.M., Fields H. L. Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia // Brain Res. - 6-7-1979. - Vol. 170.- P.85-93.

26. Behe P., Stern P., Wyllie D. J., Nassar M., Schoepfer R., Colquhoun D. Determination of NMDA NR1 subunit copy number in recombinant NMDA receptors // Proc. R. Soc. bond В Biol. Sci. - 22-11-1995. - Vol. 262.- P.205-213.

27. Ben Eliyahu S., Marek P., Vaccarino A. L., Mogil J. S., Sternberg W. F., Liebeskind

J. C. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat // Brain Res. - 20-3-1992. - Vol. 575.- P.304-308.

28. Bennett G.J., Xie Y. K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man // Pain. - 1988. - Vol. 33,- P.87-107.

29. Benveniste H., Drejer J., Schousboe A., Diemer N. H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis // J. Neurochem. - 1984. - Vol. 43.-P.1369-1374.

30. Bespalov A., Kudryashova M., Zvartau E. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats // Eur. J. Pharmacol. - 26-6-1998. - Vol. 351.- P.299-305.

31. Bester H., Chapman V., Besson J. M., Bernard J. F. Physiological properties of the lamina I spinoparabrachial neurons in the rat // J. Neurophysiol. - 2000. - Vol. 83.- P.2239-2259.

32. Bhave G., Karim F., Carlton S. M., Gereau R. W. Peripheral group I metabotropic glutamate receptors modulate nociception in mice // Nat. Neurosci. - 2001. - Vol. 4.- P.417-423.

33. Bian D., Ossipov M. H., Ibrahim M., Raffa R. B., Tallarida R. J., Malan T. P., Jr., Lai J., Porreca F. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum //Brain Res.

- 12-6-1999. - Vol. 831,- P.55-63.

34. Borsook D., Falkowski O., Rosen H., Comb M., Hyman S. E. Opioids modulate stress-induced proenkephalin gene expression in the hypothalamus of transgenic mice: a model of endogenous opioid gene regulation by exogenous opioids // J. Neurosci. - 1994. - Vol. 14.- P.7261-7271.

35. Borsook D., Burstein R., Becerra L. Functional imaging of the human trigeminal system: opportunities for new insights into pain processing in health and disease // J. Neurobiol. - 2004. - Vol. 61,- P. 107-125.

36. Boyce S., Wyatt A., Webb J. K., O'Donnell R., Mason G., Rigby M., Sirinathsinghji D., Hill R. G., Rupniak N. M. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn // Neuropharmacology. - 1999. - Vol. 38.- P.611-623.

37. Brennan T.J., Vandermeulen E. P., Gebhart G. F. Characterization of a rat model of incisional pain // Pain. - 1996. - Vol. 64.- P.493-501.

38. Brennan T.J., Zahn P. K., Pogatzki-Zahn E. M. Mechanisms of incisional pain // Anesthesiol. Clin. North America. - 2005. - Vol. 23.- P.1-20.

39. Brennan T.J. Incisional sensitivity and pain measurements: dissecting mechanisms for postoperative pain // Anesthesiology. - 2005. - Vol. 103.- P.3-4.

40. Brimecombe J.C., Boeckman F. A., Aizenman E. Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors // Proc. Natl. Acad. Sci. U. S. A. - 30-9-1997. - Vol. 94.- P.11019-11024.

41. Bruno V., Battaglia G., Casabona G., Copani A., Caciagli F., Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta// J. Neurosci. - 1-12-1998. - Vol. 18.- P.9594-9600.

42. Bruno V., Battaglia G., Copani A., Casabona G., Storto M., Di G. G., V, Ngomba R., Nicoletti F. Metabotropic glutamate receptors and neurodegeneration // Prog. Brain Res. - 1998. - Vol. 116.-P.209-221.

43.

Budai D., Wilcox G. L., Larson A. A. Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo // Neurosci. Lett. - 3-2-1992. - Vol. 135.- P.265-268.

44. Buerkle H., Marsala M., Yaksh T. L. Effect of continuous spinal remifentanil infusion on behaviour and spinal glutamate release evoked by subcutaneous formalin in the rat // Br. J. Anaesth. - 1998. - Vol. 80.- P.348-353.

45. Bushnell T.G., Craig J. Response of chronic neuropathic pain syndromes to ketamine: a role for norketamine? // Pain. - 1995. - Vol. 60.- P.l 15.

46. Byas-Smith M.G., Max M. B., Muir J., Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design//Pain. - 1995. - Vol. 60.- P.267-274.

47. Carlton S.M., Lekan H. A., Kim S. H., Chung J. M. Behavioral manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primate//Pain. - 1994.-Vol. 56.- P.155-166.

48. Carlton S.M., Hargett G. L. Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats // Neurosci. Lett. - 29-9-1995. - Vol. 198.- P. 115-118.

49. Carlton S.M., Zhou S., Coggeshall R. E. Peripheral GABA(A) receptors: evidence for peripheral primary afferent depolarization // Neuroscience. - 1999. - Vol. 93.- P.713-722.

50. Carlton S.M., Coggeshall R. E. Inflammation-induced changes in peripheral glutamate receptor populations // Brain Res. - 27-2-1999. - Vol. 820.- P.63-70.

51. Carpenter K.J., Sen S., Matthews E. A., Flatters S. L., Wozniak К. M., Slusher B. S., Dickenson A. H. Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat // Neuropeptides. - 2003. - Vol. 37.- P.298-306.

52. Carr D.B., Goudas L. C., Denman W. T., Brookoff D., Staats P. S., Brennen L., Green G., Albin R., Hamilton D., Rogers M. C., Firestone L., Lavin P.

T., Mermelstein F. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study // Pain. - 2004. - Vol. 108.- P. 17-27.

53. Castro-Lopes J.M., Malcangio M., Pan В. H., Bowery N. G. Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy // Brain Res. - 15-5-1995. - Vol. 679.- P.289- 297.

54. Caterina M.J., Julius D. The vanilloid receptor: a molecular gateway to the pain pathway // Annu. Rev. Neurosci. - 2001. - Vol. 24,- P.487-517.

55. Cervero F., Laird J. M., Garcia-Nicas E. Secondary hyperalgesia and presynaptic inhibition: an update // Eur. J. Pain. - 2003. - Vol. 7.- P.345-351.

56. Chaplan S.R., Bach F. W., Pogrel J. W., Chung J. M., Yaksh T. L. Quantitative assessment of tactile allodynia in the rat paw // J. Neurosci. Methods. - 1994. - Vol. 53.-P.55-63.

57. Chaplan S.R., Malmberg A. B., Yaksh T. L. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat // J. Pharmacol. Exp. Ther. - 1997. - Vol. 280,- P.829-838.

58. Chapman A.G. Glutamate receptors in epilepsy // Prog. Brain Res. - 1998. - Vol. 116.- P.371-383.

59. Chapman C.R., Stillman, M.. Pathological pain. In: Krueger, L., Editor, 1996. Handbook of perception: pain and touch, Academic Press, New York.

60. Chen S.R., Wozniak К. M., Slusher B. S., Pan H. L. Effect of 2-(phosphono-methyl)- pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain// J. Pharmacol. Exp. Ther. - 2002. - Vol. 300.- P.662-667.

61. Chen Y., Michaelis M., Janig W., Devor M. Adrenoreceptor subtype mediating sympathetic-sensory coupling in injured sensory neurons // J. Neurophysiol. - 1996. - Vol. 76.-P.3721-3730.

62. Chizh B.A., Reissmuller E., Schlutz H., Scheede M., Haase G., Englberger W. Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil //Neuropharmacology. - 2001. - Vol. 40.- P.212-220.

63. Chow L.H., Huang E. Y., Ho S. T., Lee T. Y., Tao P. L. Dextromethorphan potentiates morphine antinociception at the spinal level in rats I I Can. J. Anaesth. - 2004.-Vol. 51.- P.905-910.

64. Clements J.D., Lester R. A., Tong G., Jahr С. E., Westbrook G. L. The time course of glutamate in the synaptic cleft // Science. - 27-11-1992. - Vol. 258.- P.1498-1501.

65. Clements J.D. Transmitter timecourse in the synaptic cleft: its role in central synaptic function//Trends Neurosci. - 1996.-Vol. 19.-P.163-171.

66. Clohisy D.R., Ogilvie С. M., Carpenter R. J., Ramnaraine M. L. Localized, tumor- associated osteolysis involves the recruitment and activation of osteoclasts // J. Orthop. Res. - 1996. - Vol. 14.- P.2-6.

67. Clohisy D.R., Ramnaraine M. L. Osteoclasts are required for bone tumors to grow and destroy bone // J. Orthop. Res. - 1998. - Vol. 16.- P.660-666.

68. Clohisy D.R., Perkins S. L., Ramnaraine M. L. Review of cellular mechanisms of tumor osteolysis // Clin. Orthop. Relat Res. - 2000. -P.104-114.

69. Clohisy D.R., Mantyh P. W. Bone cancer pain // Cancer. - 1-2-2003. - Vol. 97,- P.866-873.

70. Coda B.A., O'Sullivan B., Donaldson G., Bohl S., Chapman C. R., Shen D. D. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation//Pain. - 1997. - Vol. 72.- P.333-346.

71. Coderre T.J. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats // Mol. Neurobiol. - 1993. - Vol. 7.- P.229-246.

72. Coggeshall R.E., Lekan H. A., White F. A., Woolf C. J. А-fiber sensory input induces neuronal cell death in the dorsal horn of the adult rat spinal cord // J. Comp Neurol. - 2-7-2001. - Vol. 435.- P.276-282.

73. Collin E., Poulain P., Gauvain-Piquard A., Petit G., Pichard-Leandri E. Is disease progression the major factor in morphine 'tolerance' in cancer pain treatment? // Pain. - 1993.-Vol. 55,- P.319-326.

74. Commons K.G., van Bockstaele E. J., Pfaff D. W. Frequent colocalization of mu opioid and NMDA-type glutamate receptors at poslsynaptic sites in periaqueductal gray neurons // J. Comp Neurol. - 14-6-1999. - Vol. 408,- P.549-559.

75. Courteix C., Bardin M., Chantelauze C., Lavarenne J., Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics // Pain. - 1994.-Vol. 57.- P.153-160.

76. Couture R., Harrisson M., Vianna R. M., Cloutier F. Kinin receptors in pain and inflammation//Eur. J. Pharmacol. - 19-10-2001. - Vol. 429.- P. 161-176.

77. Croft R. Neuropathic pain in leprosy // Int. J. Lepr. Other Mycobact. Dis. - 2004. - Vol. 72.- P.171-172.

78. Danysz W., Parsons C. G., Komhuber J., Schmidt W. J., Quack G. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents— preclinical studies //Neurosci. Biobehav. Rev. - 1997. - Vol. 21.- P.455-468.

79. Danysz W., Parsons A. C. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications // Pharmacol. Rev. - 1998. - Vol. 50.-P.597-664.

80. Danysz W., Parsons C. G. GlycineB recognition site of NMDA receptors and its antagonists // Amino. Acids. - 1998. - Vol. 14.- P.205-206.

81. Davies J., Watkins J. C. Role of excitatory amino acid receptors in mono- and polysynaptic excitation in the cat spinal cord // Exp. Brain Res. - 1983. - Vol. 49.- P.280-290.

82. Deitmer J.W. Glial strategy for metabolic shuttling and neuronal function // Bioessays. - 2000. - Vol. 22.- P.747-752.

83. Dellon A.L., Swier P., Maloney С. T., Jr., Livengood M. S., Werter S. Chemotherapy-induced neuropathy: treatment by decompression of peripheral nerves //Plast. Reconstr. Surg. - 2004. - Vol. 114.- P.478-483.

84. Devers A., Galer B. S. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study // Clin. J. Pain. - 2000. - Vol. 16.- P.205-208.

85. Devor M. Relation of foraminal (lateral) stenosis to radicular pain // AJNR Am. J. Neuroradiol. - 1996. - Vol. 17.- P.1615-1617.

86. Dickenson A.H., Sullivan A. F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation // Neuropharmacology. - 1987. - Vol. 26.- P.1235- 1238.

87. Dickenson A.H. Neurophysiology of opioid poorly responsive pain // Cancer Surv. - 1994.-Vol. 21.- P.5-16.

88. Dickenson A.H., Chapman V., Green G. M. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord// Gen. Pharmacol. - 1997. - Vol. 28.- P.633-638.

89. Dickenson A.H., Suzuki R. Opioids in neuropathic pain: clues from animal studies // Eur. J. Pain. - 2005. - Vol. 9.- P.113-116.

90. Dirig D.M., Yaksh T. L. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model // J. Pharmacol. Exp. Ther. - 1995. - Vol. 275,-P.219-227.

91. Dixon W.J. Efficient analysis of experimental observations // Annu. Rev. Pharmacol. Toxicol. - 1980. - Vol. 20.- P.441-462.

92. Donovan W.H., Dimitrijevic M. R., Dahm L., Dimitrijevic M. Neurophysiological approaches to chronic pain following spinal cord injury // Paraplegia. - 1982. - Vol. 20.- P.135-146.

93. Dougherty P.J. Long-term follow-up study of bilateral above-the-knee amputees from the Vietnam War // J. Bone Joint Surg. Am. - 1999. - Vol. 81.- P.1384-1390.

94. Dray A. Kinins and their receptors in hyperalgesia // Can. J. Physiol Pharmacol. - 1997.-Vol. 75,-P.704-712.

95. Du J., Zhou S., Coggeshall R. E., Carlton S. M. N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors H Neuroscience. - 2003.-Vol. 118.-P.547-562.

96. Dubuisson D., Dennis S. G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats // Pain. - 1977.-Vol. 4.-P.161-174.

97. Dunah A.W., Luo J., Wang Y. H., Yasuda R. P., Wolfe В. B. Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contain the NR2D subunit// Mol. Pharmacol. - 1998. - Vol. 53.- P.429-437.

98. Dworkin R.H., Backonja M., Rowbotham M. C., Allen R. R., Argoff C. R., Bennett G. J., Bushnell M. C., Farrar J. T., Galer B. S., Haythomthwaite J. A., Hewitt D. J., Loeser J. D., Max M. B., Saltarelli M., Schmader К. E., Stein C., Thompson D., Turk D. C., Wallace M. S., Watkins L. R., Weinstein S. M. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations // Arch. Neurol. - 2003. - Vol. 60.-P.l524-1534.

99. Eide K., Stubhaug A., Oye I., Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia// Pain. - 1995. - Vol. 61,- P.221-228.

100. Eide P.K., Stubhaug A., Stenehjem A. E. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation // Neurosurgery. - 1995. - Vol. 37.- P.l080-1087.

101. Eide P.K., Stubhaug A. Relief of glossopharyngeal neuralgia by ketamine- induced N-methyl-aspartate receptor blockade // Neurosurgery. - 1997. - Vol. 41.- P.505-508.

102. Eide P.K. Wind-up and the NMDA receptor complex from a clinical perspective // Eur. J. Pain. - 2000. - Vol. 4.- P.5-15.

103. Eisenach J.C., Lysak S. Z., Viscomi С. M. Epidural clonidine analgesia following surgery: phase I // Anesthesiology. - 1989. - Vol. 71.- P.640-646.

104. Eisenach J.C. Three novel spinal analgesics: clonidine, neostigmine, amitriptyline // Reg Anesth. - 1996. - Vol. 21.- P.81-83.

105. Eisenberg E., Vos В. P., Strassman A. M. The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain // Pain. - 1993. - Vol. 54,- P.301-307.

106. Eliav E., Herzberg U., Ruda M. A., Bennett G. J. Neuropathic pain from an experimental neuritis of the rat sciatic nerve // Pain. - 1999. - Vol. 83.- P.169-182.

107. Elliott K., Hynansky A., Inturrisi С. E. Dextromethorphan attenuates and reverses analgesic tolerance to morphine // Pain. - 1994. - Vol. 59.- P.361-368.

108. Enarson M.C., Hays H., Woodroffe M. A. Clinical experience with oral ketamine // J. Pain Symptom. Manage. - 1999. - Vol. 17.- P.384-386.

109. Enna S.J., Bowery N. G. GABA(B) receptor alterations as indicators of physiological and pharmacological function // Biochem. Pharmacol. - 15-10-2004. - Vol. 68.-P.1541-1548.

110. Esser M.J., Sawynok J. Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects // Pain. - 1999. - Vol. 80.- P.643-653.

111. Fairbanks C.A., Wilcox G. L. Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance //

J. Pharmacol. Exp. Ther. - 1997. - Vol. 282.- P.1408-1417.

112. Fairbanks C.A., Schreiber K. L., Brewer K. L., Yu C. G., Stone L. S., Kitto K. F., Nguyen H. O., Grocholski В. M., Shoeman D. W., Kehl L. J., Regunathan S., Reis D. J., Yezierski R. P., Wilcox G. L. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury // Proc. Natl. Acad. Sci. U. S. A. - 12-9-2000. - Vol. 97.- P.10584-10589.

113. Farber N.B., Foster J., Duhan N. L., Olney J. W. alpha 2 adrenergic agonists prevent MK-801 neurotoxicity // Neuropsychopharmacology. - 1995. - Vol. 12.- P.347-349.

114. Felsby S., Nielsen J., Arendt-Nielsen L., Jensen T. S. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride // Pain. - 1996. - Vol. 64.- P.283-291.

115. Ferreira J., da Silva G. L., Calixto J. B. Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice // Br. J. Pharmacol. - 2004. - Vol. 141.- P.787-794.

116. Fields H.L. Pain: an unpleasant topic // Pain. - 1999. - Vol. Suppl 6.- P.S61- S69.

117. Fisher K., Coderre T. J., Hagen N. A. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions // J. Pain Symptom. Manage. - 2000. - Vol. 20.-P.358-373.

118. Fride E. Endocannabinoids in the central nervous system-an overview // Prostaglandins Leukot. Essent. Fatty Acids. - 2002. - Vol. 66,- P.221-233.

119. Fromm G.H., Aumentado D., Terrence C. F. A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia // Pain. - 1993. - Vol. 53.-P.265-271.

120. Fu K.Y., Light A. R., Matsushima G. K., Maixner W. Microglial reactions after subcutaneous formalin injection into the rat hind paw // Brain Res. - 17-4-1999. -Vol. 825.-P.59-67.

121. Galbraith A.W. Prevention of post-herpetic neuralgia by amantadine hydrochloride (Symmetrel) //Br. J. Clin. Pract. - 1983. - Vol. 37.- P.304-306.

122. Galer B.S., Harle J., Rowbotham M. C. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study // J. Pain Symptom. Manage. - 1996. - Vol. 12.- P. 161-167.

123. Gilbert S.D., Clark T. M., Flores С. M. Antihyperalgesic activity of epibatidine in the formalin model of facial pain // Pain. - 2001. - Vol. 89.- P.159-165.

124. Gordon D.B., Love G. Pharmacologic management of neuropathic pain // Pain Manag. Nurs. - 2004. - Vol. 5.- P. 19-33.

125. Grauert M., Bechtel W. D., Ensinger H. A., Merz H., Carter A. J. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex // J. Med. Chem. - 29-8-1997. - Vol. 40.- P.2922-2930.

126. Guay D.R. Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain // Am. J. Geriatr. Pharmacother. - 2003. - Vol. 1.- P.18-37.

127. Haberny K.A., Paule M. G., Scallet A. C., Sistare F. D., Lester D. S., Hanig J. P., Slikker W., Jr. Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity // Toxicol. Sci. - 2002. - Vol. 68.- P.9-17.

128. Hansson M., Bostrom C., Harms-Ringdahl K. Living with spine-related pain in a changing society—a qualitative study // Disabil. Rehabil. - 10-5-2001. - Vol. 23.- P.286-295.

129. Hansson P.T., Dickenson A. H. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies //Pain. - 2005. - Vol. 113.- P.251-254.

130. Hao J.X., Xu X. J., Aldskogius H., Seiger A., Wiesenfeld-FIallin Z. Allodynia- like effects in rat after ischaemic spinal cord injury photochemically induced by laser irradiation H Pain. - 1991. - Vol. 45.- P.175-185.

131. Harden R.N. Chronic neuropathic pain. Mechanisms, diagnosis, and treatment //Neurologist. - 2005. - Vol. 11.- P.l 11-122.

132. Harrison J.K., D'Angelo D. D., Zeng D. W., Lynch K. R. Pharmacological characterization of rat alpha 2-adrenergic receptors // Mol. Pharmacol. - 1991. - Vol. 40,-P.407-412.

133. Head H., Holmes, G. Sensory disturbances from cerebral lesions // Brain. - 1911. Vol. 34.-P. 102-254.

134. Heinricher M.M., Schouten J. C., Jobst E. E. Activation of brainstem N- methyl-D-aspartate receptors is required for the analgesic actions of morphine given systemically // Pain. - 2001. - Vol. 92.- P. 129-138.

135. Herrero J.F., Laird J. M., Lopez-Garcia J. A. Wind-up of spinal cord neurones and pain sensation: much ado about something? // Prog. Neurobiol. - 2000. - Vol. 61.- P. 169-203.

136. Hesselink M.B., De Boer B. G., Breimer D. D., Danysz W. Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study H Pharm. Res. - 1999. - Vol. 16.- P.637-642.

137. Hoffmann O., Wiesenfeld-Hallin Z. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats // Neuroreport. - 29-2-1996. - Vol. 7.-P.838-840.

138. Hohmann A.G., Herkenham M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study H Neuroscience. - 1999. - Vol. 90,- P.923- 931.

139. Honore P., Rogers S. D., Schwei M. J., Salak-Johnson J. L., Luger N. M., Sabino M. C., Clohisy D. R., Mantyh P. W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons //Neuroscience. - 2000. - Vol. 98.- P.585-598.

140. Hsu M.M., Wong C. S. The roles of pain facilitatory systems in opioid tolerance // Acta Anaesthesiol. Sin. - 2000. - Vol. 38.- P. 155-166.

141. Hudson L.J., Bevan S., McNair K., Gentry C., Fox A., Kuhn R., Winter J. Metabotropic glutamate receptor 5 upregulation in А-fibers after spinal nerve injury: 2-methyl-6-(phenyIethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia // J. Neurosci. - 1-4-2002. - Vol. 22.- P.2660-2668.

142. Hwang J.H., Yaksh T. L. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat // Reg Anesth. - 1997.-Vol. 22.- P.249-256.

143. Jacquet Y.F., Squires R. F. Excitatory amino acids: role in morphine excitation in rat periaqueductal gray // Behav. Brain Res. - 1-11-1988. - Vol. 31.- P.85-88.

144. Jane D.E., Thomas N. K., Tse H. W., Watkins J. C. Potent antagonists at the L-AP4- and (lS,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord // Neuropharmacology. - 1996. - Vol. 35.- P.1029- 1035.

145. Janig W., Levine J. D., Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma // Prog. Brain Res. - 1996. -Vol. 113.-P.161-184.

146. Jannetta P.J. Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia // J. Neurosurg. - 1967. - Vol. 26.- P.Suppl-62.

147. Jannetta P.J. Preoperative evaluation of neurovascular compression in patients with trigeminal neuralgia by use of three-dimensional reconstruction from two types of high-resolution magnetic resonance imaging // Neurosurgery. - 2003. - Vol. 52.- P.1511.

148. Jansen M., Dannhardt G. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions 11 Eur. J. Med. Chem. - 2003. - Vol. 38.- P.661-670.

149. Jeanmonod D., Magnin M., Morel A. Thalamus and neurogenic pain: physiological, anatomical and clinical data // Neuroreport. - 1993. - Vol. 4.- P.475- 478.

150. Jevtovic-Todorovic V., Wozniak D. F., Powell S., Nardi A., Olney J. W. Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects // Brain Res. - 19-1-1998. - Vol. 781,-P.202-211.

151. Jones D.L., Sorkin L. S. Systemic gabapentin and S(+)-3-isobutyl-gamma- aminobutyric acid block secondary hyperalgesia // Brain Res. - 9-11-1998. - Vol. 810,-P.93-99.

152. Karanth S.S., Springall D. R., Kar S., Gibson S. J., Royston J. P., Banerjee D.

K., Polak J. M. Time-related decrease of substance P and CGRP in central and peripheral projections of sensory neurones in Mycobacterium leprae infected nude mice: a model for lepromatous leprosy in man // J. Pathol. - 1990. - Vol. 160,- P.335- 345.

153. Karlsson U., Sjodin J., Angeby M. K., Johansson S., Wikstrom L., Nasstrom J. Glutamate-induced currents reveal three functionally distinct NMDA receptor populations in rat dorsal horn - effects of peripheral nerve lesion and inflammation // Neuroscience. - 2002. - Vol. 112.- P.861-868.

154. Katter J.T., Burstein R., Giesler G. J., Jr. The cells of origin of the spinohypothalamic tract in cats 11 J. Comp Neurol. - 1-1-1991. - Vol. 303.- P.101- 112.

155. Kauppila T., Kontinen V. К., Pertovaara A. Influence of spinalization on spinal withdrawal reflex responses varies depending on the submodality of the test stimulus and the experimental pathophysiological condition in the rat // Brain Res. - 29-6-1998. - Vol. 797.- P.234-242.

156. Kayalioglu G., Robertson B., Kristensson K., Grant G. Nitric oxide synthase and interferon-gamma receptor immunoreactivities in relation to ascending spinal pathways to thalamus, hypothalamus, and the periaqueductal grey in the rat // Somatosens. Mot. Res. - 1999. - Vol. 16.- P.280-290.

157. Kayser V., Desmeules J., Guilbaud G. Systemic clonidine differentially modulates the abnormal reactions to mechanical and thermal stimuli in rats with peripheral mononeuropathy //Pain. - 1995. - Vol. 60.- P.275-285.

158. Kew J.N., Trube G., Kemp J. A. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones // J. Physiol. - 15-12-1996. - Vol. 497 ( Pt 3).- P.761-772.

159. Kim S.H., Chung J. M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat // Pain. - 1992. - Vol. 50.- P.355-363.

160. Kim S.H., Na H. S., Sheen K., Chung J. M. Effects of sympathectomy on a rat model of peripheral neuropathy // Pain. - 1993. - Vol. 55.- P.85-92.

161. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes // Pain. - 1997. - Vol. 73.- P.123-139.

162. Kissin I., Brown P. T., Robinson C. A., Bradley E. L., Jr. Acute tolerance in morphine analgesia: continuous infusion and single injection in rats // Anesthesiology. - 1991. - Vol. 74.- P.166-171.

163. Klepstad P., Borchgrevink P. C. Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia // Acta Anaesthesiol. Scand. - 1997. - Vol. 41.- P.422-426.

164. Komhuber J., Weller M. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy // Biol. Psychiatry. - 15-1-1997. - Vol. 41,-P.135-144.

165. Kress M., Fickenscher H. Infection by human varicella-zoster virus confers norepinephrine sensitivity to sensory neurons from rat dorsal root ganglia // FASEB

J. - 2001. - Vol. 15.- P.1037-1043.

166. Kristensen J.D., Karlsten R., Gordh T., Berge O. G. The NMDA antagonist 3- (2-carboxypiperazin-4-yl)propyI-l-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat H Pain. - 1994. - Vol. 56.- P.59-67.

167. Landsend A.S., Amiry-Moghaddam M., Matsubara A., Bergersen L., Usami S., Wenthold R. J., Ottersen О. P. Differential localization of delta glutamate receptors in the rat cerebellum: coexpression with AMPA receptors in parallel fiber- spine synapses and absence from climbing fiber-spine synapses // J. Neurosci. - 15-1- 1997.-Vol. 17.- P.834-842.

168. Laughlin T.M., Vanderah T. W., Lashbrook J., Nichols M. L., Ossipov M., Porreca F., Wilcox G. L. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors // Pain. - 1997. - Vol. 72.- P.253-260.

169. Lee Y.W., Chaplan S. R., Yaksh T. L. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model // Neurosci. Lett. - 20-10-1995.-Vol. 199.-P.111-114.

170. Lee Y.W., Yaksh T. L. Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model // Anesthesiology. - 1995. - Vol. 82.-P.741-748.

171. Likar R., Koppert W., Blatnig H., Chiari F., Sittl R., Stein C., Schafer M. Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients // J. Pain Symptom. Manage. - 2001. - Vol. 21.- P.330-337.

172. Lima D., Almeida A. The medullary dorsal reticular nucleus as a pronociceptive centre of the pain control system // Prog. Neurobiol. - 2002. - Vol. 66.-P.81-108.

173. Liu X., Sandkuhler J. Characterization of long-term potentiation of C-fiber- evoked potentials in spinal dorsal horn of adult rat: essential role of NK1 and NK2 receptors // J. Neurophysiol. - 1997. - Vol. 78,- P. 1973-1982.

174. Liu X.G., Sandkuhler J. The effects of extrasynaptic substance P on nociceptive neurons in laminae I and II in rat lumbar spinal dorsal horn // Neuroscience. - 1995. - Vol. 68.- P.1207-1218.

175. Liu X.G., Sandkuhler J. Long-term potentiation of C-fiber-evoked potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-D-aspartic acid receptor blockage // Neurosci. Lett. - 19-5-1995. - Vol. 191.- P.43-46.

176. Luger N.M., Honore P., Sabino M. A., Schwei M. J., Rogers S. D., Mach D. B., Clohisy D. R., Mantyh P. W. Osteoprotegerin diminishes advanced bone cancer pain//Cancer Res. - 15-5-2001. - Vol. 61.-P.4038-4047.

177. Luger N.M., Mach D. B., Sevcik M. A., Mantyh P, W. Bone cancer pain: from model to mechanism to therapy // J. Pain Symptom. Manage. - 2005. - Vol. 29.- P.S32-S46.

178. MacFarlane B.V., Wright A., O'Callaghan J., Benson H. A. Chronic neuropathic pain and its control by drugs // Pharmacol. Ther. - 1997. - Vol. 75.- P.l- 19.

179. Mao J., Price D. D., Hayes R. L., Lu J., Mayer D. J. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy // Brain Res. - 11-12- 1992.-Vol. 598.-P.271-278.

180. Mao J., Price D. D., Zhu J., Lu J., Mayer D. J. The inhibition of nitric oxide- activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat // Pain. - 1997. - Vol. 72.- P.355-366.

181. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity // Brain Res. Brain Res. Rev. - 1999. - Vol. 30.- P.289- 304.

182. Marchettini P., Lacerenza M., Marangoni C., Pellegata G., Sotgiu M. L., Smime S. Lidocaine test in neuralgia // Pain. - 1992. - Vol. 48.- P.377-382.

183. Martin L.A., Hagen N. A. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies // J. Pain Symptom. Manage. - 1997. - Vol. 14.-P.99-117.

184. Max M.B., Byas-Smith M. G., Gracely R. H., Bennett G. J. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo // Clin. Neuropharmacol. - 1995. - Vol. 18.- P.360-368.

185. McBain C.J., Mayer M. L. N-methyl-D-aspartic acid receptor structure and function // Physiol Rev. - 1994. - Vol. 74.- P.723-760.

186. McCleane G.J. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study // Anesth. Analg. - 1999. - Vol. 89.- P.985-988.

187. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing // Pain. - 1994. - Vol. 59.- P.9-43.

188. McLachlan E.M., Janig W., Devor M., Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia // Nature. - 10-6-1993. - Vol. 363.- P.543-546.

189. McNicol E., Strassels S. A., Goudas L., Lau J., Carr D. B. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain // Cochrane. Database. Syst. Rev. - 2005. -P.CD005180.

190. McQuay H.J., Carroll D., Jadad A. R., Glynn C. J., Jack T., Moore R. A., Wiffeh P. J. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design // Pain. - 1994. - Vol. 59.-P.127-133.

191. Medhurst S.J., Walker K., Bowes M., Kidd B. L., Glatt M., Muller M., Hattenberger M., Vaxelaire J., O'Reilly T., Wotherspoon G., Winter J., Green J., Urban L. A rat model of bone cancer pain // Pain. - 2002. - Vol. 96.- P.129-140.

192. Medvedev I.O., Malyshkin A. A., Belozertseva I. V., Sukhotina I. A., Sevostianova N. Y., Aliev K., Zvartau E. E., Parsons C. G., Danysz W., Bespalov A. Y. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain //Neuropharmacology. - 2004. - Vol. 47.- P.175-183.

193. Meldrum B.S. The glutamate synapse as a therapeutical target: perspectives for the future//Prog. Brain Res. - 1998. - Vol. 116.-P.441-458.

194. Melzack R., Coderre T. J., Katz J., Vaccarino A. L. Central neuroplasticity and pathological pain // Ann. N. Y. Acad. Sci. - 2001. - Vol. 933,- P.157-174.

195. Melzack R., Wall P.D. Pain mechanisms: a new theory // Science. - 1965. - Vol. 150.-P. 971-979.

196. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain //Pain. - 1993. - Vol. 54.- P.241-289.

197. Mercadante S., Lodi F., Sapio M., Calligara M., Serretta R. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain // J. Pain Symptom. Manage. - 1995. - Vol. 10.- P.564-568.

198. Merskey H., N. Bogduk. Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms (2nd ed.), IASP Press, Seattle, WA (1994).

199. Meyerson B.A., Linderoth B. Mechanisms of spinal cord stimulation in neuropathic pain // Neurol. Res. - 2000. - Vol. 22.- P.285-292.

200. Michaelis M., Liu X., Janig W. Axotomized and intact muscle afferents but no skin afferents develop ongoing discharges of dorsal root ganglion origin after peripheral nerve lesion // J. Neurosci. - 1-4-2000. - Vol. 20.- P.2742-2748.

201. Miki K., Zhou Q. Q., Guo W., Guan Y., Terayama R., Dubner R., Ren K. Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation // J. Neurophysiol. - 2002. - Vol. 87.- P.750-760.

202. Millan M.J., Bervoets К., Rivet J. M., Widdowson P., Renouard A., Marouille-Girardon S., Gobert A. Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline H J. Pharmacol. Exp. Ther. - 1994. - Vol. 270.- P.958-972.

203. Millan M.J., Seguin L. Chemically-diverse ligands at the glycine В site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice // Neurosci. Lett. - 29-8-1994. - Vol. 178.- P.139- 143.

204. Millan M.J. The induction of pain: an integrative review 11 Prog. Neurobiol. - 1999.-Vol. 57,- P.1-164.

205. Mills C.D., Fullwood S. D., Hulsebosch С. E. Changes in metabotropic glutamate receptor expression following spinal cord injury // Exp. Neurol. - 2001. - Vol. 170.- P.244-257.

206. Misztal M., Frankiewicz T., Parsons C. G., Danysz W. Learning deficits induced by chronic intraventricular infusion of quinolinic acid—protection by MK- 801 and memantine //Eur. J. Pharmacol. - 18-1-1996. - Vol. 296.- P.1-8.

207. Mitchell J.M., Lowe D., Fields H. L. The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats //Neuroscience. - 1998. - Vol. 87.- P.123-133.

208. Mitsikostas D.D., Sanchez d. R., Waeber C., Moskowitz M. A., Cutrer F. M. The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis // Pain. - 1998. - Vol. 76.- P.239-248.

209. Monhemius R., Green D. L., Roberts M. H., Azami J. Periaqueductal grey mediated inhibition of responses to noxious stimulation is dynamically activated in a rat model of neuropathic pain // Neurosci. Lett. - 26-1-2001. - Vol. 298.- P.70-74.

210. Monyer H., Bumashev N., Laurie D. J., Sakmann B., Seeburg P. H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors //Neuron. - 1994. - Vol. 12.- P.529-540.

211. Moon D.E., Lee D. H., Han H. C., Xie J., Coggeshall R. E., Chung J. M. Adrenergic sensitivity of the sensory receptors modulating mechanical allodynia in a rat neuropathic pain model // Pain. - 1999. - Vol. 80,- P.589-595.

212. Moore K.A., Baba H., Woolf C. J. Synaptic transmission and plasticity in the superficial dorsal horn // Prog. Brain Res. - 2000. - Vol. 129,- P.63-80.

213. Moore R.A., Tramer M. R., Carroll D., Wiffen P. J., McQuay H. J. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs // BMJ. - 31-1-1998. - Vol. 316.- P.333-338.

214. Morris R., Cheunsuang O., Stewart A., Maxwell D. Spinal dorsal horn neurone targets for nociceptive primary afferents: do single neurone morphological characteristics suggest how nociceptive information is processed at the spinal level // Brain Res. Brain Res. Rev. - 2004. - Vol. 46.- P.173-190.

215. Na H.S., Han J. S., Ко К. H., Hong S. K. A behavioral model for peripheral neuropathy produced in rat's tail by inferior caudal trunk injury // Neurosci. Lett. - 15-8-1994. - Vol. 177.- P.50-52.

216. Nagy G.G., Watanabe M., Fukaya M., Todd A. J. Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique // Eur. J. Neurosci. - 2004. - Vol. 20.- P.3301-3312.

217. Namaka M., Gramlich C. R., Ruhlen D., Melanson M., Sutton I., Major J. A treatment algorithm for neuropathic pain // Clin. Ther. - 2004. - Vol. 26.- P.951-979.

218. Neil A., Kayser V., Gacel G., Besson J. M., Guilbaud G. Opioid receptor types and antinociceptive activity in chronic inflammation: both kappa- and mu-opiate agonistic effects are enhanced in arthritic rats // Eur. J. Pharmacol. - 4-11-1986. - Vol. 130.- P.203-208.

219. Nelson K.A., Park К. M., Robinovitz E., Tsigos C., Max M. B. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia//Neurology. - 1997. - Vol. 48.- P.1212-1218.

220. Nesic O., Svrakic N. M., Xu G. Y., McAdoo D., Westlund K. N., Hulsebosch С. E., Ye Z., Galante A., Soteropoulos P., Tolias P., Young W., Hart R. P., Perez- Polo J. R. DNA microarray analysis of the contused spinal cord: effect of NMDA receptor inhibition П J. Neurosci. Res. - 15-5-2002. - Vol. 68.- P.406-423.

221. Neugebauer V., Lucke T., Schaible H. G. Differential effects of N-methyl-D- aspartate (NMDA) and non-NMDA receptor antagonists on the responses of rat spinal neurons with joint input // Neurosci. Lett. - 28-5-1993. - Vol. 155.- P.29-32.

222. Neugebauer V., Lucke T., Grubb B., Schaible H. G. The involvement of N- methyl-D-aspartate (NMDA) and non-NMDA receptors in the responsiveness of rat spinal neurons with input from the chronically inflamed ankle 11 Neurosci. Lett. -11- 4-1994. - Vol. 170.- P.237-240.

223. Neugebauer V. Peripheral metabotropic glutamate receptors: fight the pain where it hurts // Trends Neurosci. - 2001. - Vol. 24,- P.550-552.

224. Neugebauer V. Metabotropic glutamate receptors—important modulators of nociception and pain behavior // Pain. - 2002. - Vol. 98.- P.l-8.

225. Nichols M.L., Lopez Y., Ossipov M. H., Bian D., Porreca F. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy П Pain. - 1997. - Vol. 69.- P.317-322.

226. Nikolajsen L., Hansen C. L., Nielsen J., Keller J., Arendt-Nielsen L., Jensen T. S. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input // Pain. - 1996. - Vol. 67.- P.69-77.

227. Nikolajsen L., Hansen P. O., Jensen T. S. Oral ketamine therapy in the treatment of postamputation stump pain // Acta Anaesthesiol. Scand. - 1997. - Vol. 41,- P.427-429.

228. Nowak L., Bregestovski P., Ascher P., Herbet A., Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones // Nature. - 2-2-1984. - Vol. 307.- P.462-465.

229. Nozaki-Taguchi N., Chaplan S. R., Higuera E. S., Ajakwe R. C., Yaksh T. L. Vincristine-induced allodynia in the rat I I Pain. - 2001. - Vol. 93.- P.69-76.

230. Ogawa T., Mimura Y., Kato H., Ootsubo S., Murakoshi M. The usefulness of rabbits as an animal model for the neuropathological assessment of neurotoxicity following the administration of vincristine // Neurotoxicology. - 2000. - Vol. 21.- P.501-511.

231. Olivar T., Laird J. M. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes // Pain. - 1999. - Vol. 79.- P.67-73.

232. Olney J.W., Ikonomidou C., Mosinger J. L., Frierdich G. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain // J. Neurosci. - 1989. - Vol. 9,- P.1701-1704.

233. Olney J.W., Farber N. B. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia // Neuropsychopharmacology. - 1995. - Vol. 13.-P.335-345.

234. Olson T.H., Riedl M. S., Vulchanova L., Ortiz-Gonzalez X. R., Elde R. An acid sensing ion channel (ASIC) localizes to small primary afferent neurons in rats // Neuroreport. - 20-4-1998. - Vol. 9.- P. 1109-1113.

235. Olszewski R.T., Bukhari N., Zhou J., Kozikowski A. P., Wroblewski J. T., Shamimi-Noori S., Wroblewska B.5 Bzdega T., Vicini S., Barton F. B., Neale J. FI. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR // J. Neurochem. - 2004. - Vol. 89.- P.876-885.

236. Ong C.K., Lirk P., Seymour R. A., Jenkins B. J. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis // Anesth. Analg. - 2005. - Vol. 100.- P.757-73, table.

237. Ossipov M.H., Lopez Y., Nichols M. L., Bian D., Porreca F. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury//Neurosci. Lett. - 20-10-1995. - Vol. 199.- P.83-86.

238. Ossipov M.H., Lai J., Malan T. P., Jr., Porreca F. Spinal and supraspinal mechanisms of neuropathic pain // Ann. N. Y. Acad. Sci. - 2000. - Vol. 909.- P.12- 24.

239. Oza A.M., Elit L., Swenerton K., Faught W., Ghatage P., Carey M., McIntosh

L. , Dorr A., Holmlund J. T., Eisenhauer E. Phase II study of CGP 69846A (ISIS 5132) in'recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116) H Gynecol. Oncol. - 2003. - Vol. 89.- P.129-133.

240. Pan H.L., Chen S. R., Eisenach J. C. Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors // Anesthesiology. - 1999. - Vol. 90.- P.509-514.

241. Paoletti P., Ascher P., Neyton J. High-affinity zinc inhibition of NMDA NR1- NR2A receptors // J. Neurosci. - 1-8-1997. - Vol. 17.- P.5711-5725.

242. Parsons C.G., Quack G., Bresink I., Baran L., Przegalinski E., Kostowski W., Krzascik P., Hartmann S., Danysz W. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo // Neuropharmacology. - 1995. - Vol. 34,- P.1239-1258.

243. Parsons C.G., Danysz W., Quack G. Glutamate in CNS disorders as a target for drug development: an update // Drug News Perspect. - 1998. - Vol. 11.- P.523- 569.

244. Parsons C.G., Danysz W., Bartmann A., Spielmanns P., Frankiewicz T., Hesselink M., Eilbacher B., Quack G. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization // Neuropharmacology. - 1999. -Vol. 38,-P.85-108.

245. Parsons C.G., Danysz W., Quack G. Memantine and the amino-alkyl- cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation // Amino. Acids. - 2000. - Vol. 19.- P.157-166.

246. Parsons C.G. NMDA receptors as targets for drug action in neuropathic pain // Eur. J. Pharmacol. - 19-10-2001. - Vol. 429.- P.71-78.

247. Patel S., Naeem S., Kesingland A., Froestl W., Capogna M., Urban L., Fox A. The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat // Pain. - 15-2-2001. - Vol. 90.- P.217-226.

248. Persson J., Axelsson G., Hallin R. G., Gustafsson L. L. Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization // Pain. - 1995. - Vol. 60.- P.217-222.

249. Persson J., Hasselstrom J., Wiklund B., Heller A., Svensson J. O., Gustafsson L. L. The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans // Acta Anaesthesiol. Scand. - 1998. - Vol. 42.- P.750-758.

250. Pertovaara A., Wei H. Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers // Eur. J. Pharmacol. - 19-10-2001. - Vol. 429.- P.139-145.

251. Pertovaara A., Wei H. A dissociative change in the efficacy of supraspinal versus spinal morphine in the neuropathic rat // Pain. - 2003. - Vol. 101.- P.237-250.

252. Petrenko A.B., Yamakura T., Baba H., Shimoji K. The role of N-methyl-D- aspartate (NMDA) receptors in pain: a review H Anesth. Analg. - 2003. - Vol. 97.- P.l 108-1116.

253. Phillips W.J., Currier B. L. Analgesic pharmacology: II. Specific analgesics //

J. Am. Acad. Orthop. Surg. - 2004. - Vol. 12.- P.221-233.

254. Pieper G.M., Mizoguchi H., Ohsawa M., Kamei J., Nagase H., Tseng L. F. Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse // Eur. J. Pharmacol. - 11-8-2000. - Vol. 401.- P.375- 379.

255. Popik P., Danysz W. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D- aspartate receptor antagonist, memantine // J. Pharmacol. Exp. Ther. - 1997. - Vol. 280.-P.854-865.

256. Portenoy R.K., Foley К. M., Inturrisi С. E. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions // Pain. - 1990. - Vol. 43.- P.273-286.

257. Portenoy R.K., Hagen N. A. Breakthrough pain: definition, prevalence and characteristics H Pain. - 1990. - Vol. 41.- P.273-281.

258. Portera-Cailliau C., Price D. L., Martin L. J. N-methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies // J. Neurochem. - 1996. - Vol. 66.- P.692-700.

259. Przewlocki R., Przewlocka B. Opioids in chronic pain // Eur. J. Pharmacol. - 19-10-2001. - Vol. 429,- P.79-91.

260. Pud D., Eisenberg E., Spitzer A., Adler R., Fried G., Yamitsky D. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial // Pain. - 1998. - Vol. 75.- P.349- 354.

261. Puttfarcken P.S., Handen J. S., Montgomery D. T., Coyle J. T., Werling L. L. N-acetyl-aspartylglutamate modulation of N-methyl-D-aspartate-stimulated [3H]norepinephrine release from rat hippocampal slices // J. Pharmacol. Exp. Ther. - 1993.-Vol. 266.- P.796-803.

262. Raboisson P., Flood K., Lehmann A., Berge O. G. MK-801 neurotoxicity in the guinea pig cerebral cortex: susceptibility and regional differences compared with the rat// J. Neurosci. Res. - 1-8-1997. - Vol. 49.- P.364-371.

263. Raja S.N., Davis K. D., Campbell J. N. The adrenergic pharmacology of sympathetically-maintained pain // J. Reconstr. Microsurg. - 1992. - Vol. 8.- P.63-69.

264. Ramer M., Bisby M. Reduced sympathetic sprouting occurs in dorsal root ganglia after axotomy in mice lacking low-affinity neurotrophin receptor // Neurosci. Lett. - 30-5-1997. - Vol. 228.- P.9-12.

265. Ramer M.S., Murphy P. G., Richardson P. M., Bisby M. A. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice // Pain. - 1998. - Vol. 78.- P.l 15-121.

266. Randic M., Jiang M. C., Ceme R. Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord // J. Neurosci. - 1993. - Vol. 13.- P.5228-5241.

267. Rasmussen P. Facial pain. IV. A prospective study of 1052 patients with a view of: precipitating factors, associated symptoms, objective psychiatric and neurological symptoms //Acta Neurochir. (Wien.). - 1991. - Vol. 108.- P.100-109.

268. Regan J.M., Peng P. Neurophysiology of cancer pain // Cancer Control. -

2000. -Vol. 7.-P.l 11-119.

269. Ren K., Hylden J. L., Williams G. M., Ruda M. A., Dubner R. The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation // Pain. - 1992. -Vol. 50.-P.331-344.

270. Ren K., Dubner R. Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation // J. Neurophysiol. - 1996. - Vol. 76,- P.3025- 3037.

271. Ren K., Dubner R. Central nervous system plasticity and persistent pain // J. Orofac. Pain. - 1999. - Vol. 13.- P.155-163.

272. Ren K., Dubner R. Descending modulation in persistent pain: an update // Pain. - 2002. - Vol. 100.- P.1-6.

273. Reynolds D.V. Surgery in the rat during electrical analgesia induced by focal brain stimulation// Science. - 25-4-1969. - Vol. 164.- P.444-445.

274. Rice A.S. Cannabinoids and pain // Curr. Opin. Investig. Drugs. - 2001. - Vol. 2.-P.399-414.

275. Rice A.S., Farquhar-Smith W. P., Nagy I. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy // Prostaglandins Leukot. Essent. Fatty Acids. - 2002. - Vol. 66.- P.243-256.

276. Rogawski M.A. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines // Trends Pharmacol. Sci. - 1993. - Vol. 14.-P.325-331.

277. Romanelli P., Esposito V. The functional anatomy of neuropathic pain // Neurosurg. Clin. N. Am. - 2004. - Vol. 15.- P.257-268.

278. Rothstein J.D., Martin L., Levey A. I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R. W. Localization of neuronal and glial glutamate transporters // Neuron. - 1994.-Vol. 13,-P.713-725.

279. Rowbotham M.C., Reisner-Keller L. A., Fields FI. L. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia // Neurology. - 1991.-Vol. 41,- P.1024-1028.

280. Rowbotham M.C., Davies P. S., Fields H. L. Topical lidocaine gel relieves postherpetic neuralgia // Ann. Neurol. - 1995. - Vol. 37.- P.246-253.

281. Rowbotham M.C., Davies P. S., Verkempinck C., Galer B. S. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia // Pain. - 1996. - Vol. 65.- P.39-44.

282. Ruess L., O'Connor S. C., Cho К. H., Hussain F. H., Howard W. J., Ill, Slaughter R. C., Hedge A. Carpal tunnel syndrome and cubital tunnel syndrome: work-related musculoskeletal disorders in four symptomatic radiologists // AJR Am. J. Roentgenol. - 2003. - Vol. 181.- P.37-42.

283. Sabino M.A., Ghilardi J. R., Jongen J. L., Keyser С. P., Luger N. M., Mach D. B., Peters С. M., Rogers S. D., Schwei M. J., de Felipe C., Mantyh P. W. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2 // Cancer Res. - 15-12-2002. - Vol. 62.- P.7343-7349.

284. Sandkuhler J. Learning and memory in pain pathways // Pain. - 2000. - Vol. 88.- P.113-118.

285. Sawynok J., Esser M. J., Reid A. R. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat // Pain. - 1999. - Vol. 82.- P.149-158.

286. Sawynok J., Esser M. J., Reid A. R. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action // J. Psychiatry Neurosci. -

2001. -Vol. 26,-P.21-29.

287. Sawynok J. Topical and peripherally acting analgesics // Pharmacol. Rev. - 2003. - Vol. 55.-P. 1-20.

288. Schaible H.G., Ebersberger A., Von Banchet G. S. Mechanisms of pain in arthritis // Ann. N. Y. Acad. Sci. - 2002. - Vol. 966.- P.343-354.

289. Schechtmann G., Wallin J., Meyerson B. A., Linderoth B. Intrathecal clonidine potentiates suppression of tactile hypersensitivity by spinal cord stimulation in a model of neuropathy // Anesth. Analg. - 2004. - Vol. 99.- P.135-139.

290. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system // J. Pharmacol. Exp. Ther. - 2001. - Vol. 299.-P.12-20.

291. Schouenborg J., Sjolund В. H. Activity evoked by A- and C-afferent fibers in rat dorsal horn neurons and its relation to a flexion reflex // J. Neurophysiol. - 1983. - Vol. 50.- P.1108-1121.

292. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury // Pain. - 1990. - Vol. 43.- P.205-218.

293. Shi T.S., Winzer-Serhan U., Leslie F., Hokfelt T. Distribution and regulation of alpha(2)-adrenoceptors in rat dorsal root ganglia // Pain. - 2000. - Vol. 84.- P.319- 330.

294. Siegel S. State dependent learning and morphine tolerance // Behav. Neurosci. - 1988. - Vol. 102.- P.228-232.

295. Sindrup S.H., Jensen T. S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action // Pain. -

1999. - Vol. 83.- P.389-400.

296. Sluka K.A., Willis W. D. Increased spinal release of excitatory amino acids following intradermal injection of capsaicin is reduced by a protein kinase G inhibitor // Brain Res. - 6-7-1998. - Vol. 798,- P.281-286.

297. Smith G.D., Harrison S. M., Birch P. J., Elliott P. J., Malcangio M., Bowery N. G. Increased sensitivity to the antinociceptive activity of (+/-)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia // Neuropharmacology. - 1994. - Vol. 33.- P.l 103-1108.

298. Sorensen J., Bengtsson A., Backman E., Henriksson K. G., Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine // Scand. J. Rheumatol. - 1995. - Vol. 24.- P.360-365.

299. Sorensen J., Bengtsson A., Ahlner J., Henriksson K. G., Ekselius L., Bengtsson M. Fibromyalgia—are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs // J. Rheumatol. - 1997.-Vol. 24.- P.1615-1621.

300. Sotgiu M.L., Biella G. Differential effects of MK-801, a N-methyl-D-aspartate non-competitive antagonist, on the dorsal horn neuron hyperactivity and hyperexcitability in neuropathic rats //Neurosci. Lett. - 7-4-2000. - Vol. 283,- P.153- 156.

301. Stanfa L.C., Sullivan A. F., Dickenson A. H. Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan- induced inflammation //Pain. - 1992. - Vol. 50.- P.345-354.

302. Stanfa L.C., Dickenson A. H. Inflammation alters the effects of mGlu receptor agonists on spinal nociceptive neurones // Eur. J. Pharmacol. - 24-4-1998. - Vol. 347.-P.165-172.

303. Stannard C.F., Porter G. E. Ketamine hydrochloride in the treatment of phantom limb pain // Pain. - 1993. - Vol. 54.- P.227-230.

304. Stein C. Peripheral mechanisms of opioid analgesia // Anesth. Analg. - 1993. - Vol. 76.-P.182-191.

305. Stein C., Yassouridis A. Peripheral morphine analgesia // Pain. - 1997. - Vol. 71.- P.119-121.

306. Stephens D.N., Cole B. J. AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks // Psychopharmacology (Berl). - 1996. - Vol. 126,- P.249-259.

307. Stevens C.W. Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents // Cancer Surv. - 1994. - Vol. 21.- P.25-47.

308. Su X., Gebhart G. F. Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon // Pain. - 1998. - Vol. 76.- P.105-114.

309. Sueoka N., Sueoka E., Okabe S., Fujiki H. Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression // Carcinogenesis. - 1996. - Vol. 17.- P.2337-2341.

310. Suzuki T., Kishimoto Y., Ozaki S., Narita M. Mechanism of opioid dependence and interaction between opioid receptors // Eur. J. Pain. - 2001. - Vol. 5 Suppl A.- P.63-65.

311. Takahashi H., Miyazaki M., Nanbu T., Yanagida H., Morita S. The NMDA- receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case // Pain. - 1998. - Vol. 75,- P.391-394.

312. Takahashi T., Feldmeyer D., Suzuki N., Onodera K., Cull-Candy S. G., Sakimura K., Mishina M. Functional correlation of NMDA receptor epsilon subunits expression with the properties of single-channel and synaptic currents in the developing cerebellum // J. Neurosci. - 15-7-1996. - Vol. 16.- P.4376-4382.

313. Tai M., Bennett G. J. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat//Neurosci. Lett. - 5-3-1993. - Vol. 151.- P.107-110.

314. Tai M., Bennett G. J. Neuropathic pain sensations are differentially sensitive to dextrorphan//Neuroreport. - 21-7-1994. - Vol. 5.- P.1438-1440.

315. Tallarida R.J., Kimmel H. L., Holtzman S. G. Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine // Psychopharmacology (Berl). - 1997. - Vol. 133.- P.378-382.

316. Tao F., Liaw W. J., Zhang B., Yaster M., Rothstein J. D., Johns R. A., Tao Y. X. Evidence of neuronal excitatory amino acid carrier 1 expression in rat dorsal root ganglion neurons and their central terminals // Neuroscience. - 2004. - Vol. 123.- P.1045-1051.

317. Taylor C.P. Mechanisms of action of gabapentin H Rev. Neurol. (Paris). - 1997. - Vol. 153 Suppl 1.- P.S39-S45.

318. Tjolsen A., Berge O. G., Hunskaar S., Rosland J. H., Hole K. The formalin test: an evaluation of the method // Pain. - 1992. - Vol. 51.- P.5-17.

319. Tracey D.J., Cunningham J. E., Romm M. A. Peripheral hyperalgesia in experimental neuropathy: mediation by alpha 2-adrenoreceptors on post-ganglionic sympathetic terminals H Pain. - 1995. - Vol. 60.- P.317-327.

320. Traynelis S.F., Hartley M., Heinemann S. F. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines // Science. - 12-5-1995. - Vol. 268.- P.873-876.

321. Trujillo K.A. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies // Psychopharmacology (Berl). -

2000. -Vol. 151.- P.121-141.

322. Urban M.O., Gebhart G. F. Characterization of biphasic modulation of spinal nociceptive transmission by neurotensin in the rat rostral ventromedial medulla // J. Neurophysiol. - 1997. - Vol. 78,- P.1550-1562.

323. Urban M.O., Coutinho S. V., Gebhart G. F. Involvement of excitatory amino acid receptors and nitric oxide in the rostral ventromedial medulla in modulating secondary hyperalgesia produced by mustard oil // Pain. - 1999. - Vol. 81.- P.45-55.

324. Valivullah H.M., Lancaster J., Sweetnam P. M., Neale J. H. Interactions between N-acetylaspartylglutamate and AMPA, kainate, and NMDA binding sites //

J. Neurochem. - 1994. - Vol. 63.- P.1714-1719.

325. van Praag H., Frenk H. The role of glutamate in opiate descending inhibition of nociceptive spinal reflexes // Brain Res. - 30-7-1990. - Vol. 524.- P.101-105.

326. Varney M.A., Gereau R. W. Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics // Curr. Drug Targets. CNS. Neurol. Disord. - 2002. - Vol. 1.- P.283-296.

327. Verdu E., Vilches J. J., Rodriguez F. J., Ceballos D., Valero A., Navarro X. Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice // Muscle Nerve. - 1999. - Vol. 22.- P.329-340.

328. Wacnik P.W., Eikmeier L. J., Ruggles T. R., Ramnaraine M. L., Walcheck B.

K. , Beitz A. J., Wilcox G. L. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain //J. Neurosci. - 1-12-2001. - Vol. 21.- P.9355-9366.

329. Waldvogel H.J., Faull R. L., Jansen K. L., Dragunow M., Richards J. G., Mohler H., Streit P. GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels //Neuroscience. - 1990. - Vol. 39.- P.361-385.

330. Walker К., Bowes M., Panesar M., Davis A., Gentry C., Kesingland A., Gasparini F., Spooren W., Stoehr N., Pagano A., Flor P. J., Vranesic I., Lingenhoehl

K., Johnson E. C., Varney M., Urban L., Kuhn R. Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain // Neuropharmacology. -

2001. -Vol. 40.-P.1-9.

331. Walker K., Medhurst S. J., Kidd B. L., Glatt M., Bowes M., Patel S., McNair

K., Kesingland A., Green J., Chan O., Fox A. J., Urban L. A. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain // Pain. - 2002. - Vol. 100.- P.219-229.

332. Wang H., Zhang R. X., Wang R., Qiao J. T. Decreased expression of N- methyl-D-aspartate (NMDA) receptors in rat dorsal root ganglion following complete Freund's adjuvant-induced inflammation: an immunocytochemical study for NMDA NR1 subunit//Neurosci. Lett. - 23-4-1999. - Vol. 265.- P.195-198.

333. Wang L.X., Wang Z. J. Animal and cellular models of chronic pain // Adv. Drug Deliv. Rev. - 28-8-2003. - Vol. 55.- P.949-965.

334. Wedzony K., Czyrak A. The role of corticosteroids in the acquisition of sensitization to locomotor stimulant effects of MK-801 // Brain Res. - 19-9-1994. - Vol. 657.-P.351-356.

335. Wegert S., Ossipov M. H., Nichols M. L., Bian D., Vanderah T. W., Malan T. P., Jr., Porreca F. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats // Pain. - 1997.-Vol. 71.- P.57-64.

336. Wei F., Dubner R., Ren K. Nucleus reticularis gigantocellularis and nucleus raphe magnus in the brain stem exert opposite effects on behavioral hyperalgesia and spinal Fos protein expression after peripheral inflammation // Pain. - 1999. - Vol. 80.-P.127-141.

337. Weng H.R., Laird J. M., Cervero F., Schouenborg J. GABAA receptor blockade inhibits A beta fibre evoked wind-up in the arthritic rat // Neuroreport. - 20- 4-1998. - Vol. 9.- P.1065-1069.

338. Westin U., Piras E., Jansson B., Bergstrom U., Dahlin M., Brittebo E., Bjork E. Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents // Eur. J. Pharm. Sci. - 2005. - Vol. 24.- P.565- 573.

339. Whiteside G.T., Harrison J., Boulet J., Mark L., Pearson M., Gottshall S., Walker K. Pharmacological characterisation of a rat model of incisional pain // Br. J. Pharmacol. - 2004. - Vol. 141,- P.85-91.

340. Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors // Mol. Pharmacol. - 1993. - Vol. 44.- P.851-859.

341. Willis W.D., Sluka K. A., Rees H., Westlund K. N. Cooperative mechanisms of neurotransmitter action in central nervous sensitization // Prog. Brain Res. - 1996. -Vol. 110,-P.151-166.

342. Willis W.D., Westlund K. N. Neuroanatomy of the pain system and of the pathways that modulate pain // J. Clin. Neurophysiol. - 1997. - Vol. 14.- P.2-31.

343. Willis W.D., Jr., Zhang X., Honda C. N., Giesler G. J., Jr. Projections from the marginal zone and deep dorsal horn to the ventrobasal nuclei of the primate thalamus //Pain. - 2001. - Vol. 92.- P.267-276.

344. Wilson S.G., Mogil J. S. Measuring pain in the (knockout) mouse: big challenges in a small mammal // Behav. Brain Res. - 1-11-2001. - Vol. 125.- P.65-73.

345. Witherell G. BMS-232632 (Novartis/Bristol-Myers Squibb) // Curr. Opin. Investig. Drugs. - 2001. - Vol. 2.- P.340-347.

346. Wong C.S., Chemg С. H., Luk H. N., Ho S. T., Tung C. S. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors // Eur. J. Pharmacol. - 15-2-1996. - Vol. 297.- P.27-33.

347. Woolf C.J. Windup and central sensitization are not equivalent // Pain. - 1996. -Vol. 66.-P.105-108.

348. Woolf C.J., Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain // Proc. Natl. Acad. Sci. U. S. A. - 6-7-1999. - Vol. 96,- P.7723-7730.

349. Yaksh T.L., Dirig D. M., Malmberg A. B. Mechanism of action of nonsteroidal anti-inflammatory drugs // Cancer Invest. - 1998. - Vol. 16.- P.509-527.

350. Yamakura T., Shimoji K. Subunit- and site-specific pharmacology of the NMDA receptor channel // Prog. Neurobiol. - 1999. - Vol. 59.- P.279-298.

351. Yamamoto T., Yaksh T. L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy // Neurosci. Lett. - 20-1-1992. - Vol. 135.- P.67-70.

352. Yamamoto T., Shimoyama N., Asano H., Mizuguchi T. Time-dependent effect of morphine and time-independent effect of MK-801, an NMDA antagonist, on the thermal hyperesthesia induced by unilateral constriction injury to the sciatic nerve in the rat// Anesthesiology. - 1994. - Vol. 80.-P.1311-1319.

353. Yamamoto T., Nozaki-Taguchi N., Sakashita Y. Spinal N-acetyl-alpha-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat // Brain Res. - 3-8-2001. - Vol. 909.- P.138- 144.

354. Yamamoto T., Hirasawa S., Wroblewska B., Grajkowska E., Zhou J., Kozikowski A., Wroblewski J., Neale J. H. Antinociceptive effects of N- acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model // Eur. J. Neurosci. - 2004. - Vol. 20.- P.483-494.

355. Yeomans D.C., Cooper B. Y., Vierck C. J., Jr. Effects of systemic morphine on responses of primates to first or second pain sensations // Pain. - 1996. - Vol. 66.- P.253-263.

356. Yezierski R.P., Schwartz R. H. Response and receptive-field properties of spinomesencephalic tract cells in the cat // J. Neurophysiol. - 1986. - Vol. 55.- P.76- 96.

357. Yezierski R.P., Park S. H. The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat // Neurosci. Lett. - 9-7- 1993.-Vol. 157.- P.115-119.

358. Yezierski R.P. Pain following spinal cord injury: pathophysiology and central mechanisms // Prog. Brain Res. - 2000. - Vol. 129.- P.429-449.

359. Yoon Y.S., Hwang I. K., Lee I. S., Suh J. G„ Shin J. W., Kang T. C., Oh Y. S., Won M. IT. Galanin-immunoreactive cells and their relation to calcitonin gene- related peptide-, substance P- and somatostatin-immunoreactive cells in rat lumbar dorsal root ganglia // Anat. Histol. Embryol. - 2003. - Vol. 32.- P.l 10-115.

360. Yoshimura M., Jessell T. Amino acid-mediated EPSPs at primary afferent synapses with substantia gelatinosa neurones in the rat spinal cord // J. Physiol. - 1990.-Vol. 430.- P.315-335.

361. Zahn P.K., Gysbers D., Brennan T. J. Effect of systemic and intrathecal morphine in a rat model of postoperative pain // Anesthesiology. - 1997. - Vol. 86.- P. 1066-1077.

362. Zahn P.K., Umali E., Brennan T. J. Intrathecal non-NMDA excitatory amino acid receptor antagonists inhibit pain behaviors in a rat model of postoperative pain // Pain. - 1998. - Vol. 74.- P.213-223.

363. Zahn P.K., Brennan T. J. Primary and secondary hyperalgesia in a rat model for human postoperative pain // Anesthesiology. - 1999. - Vol. 90.- P.863-872.

364. Zahn P.K., Pogatzki-Zahn E. M., Brennan T. J. Spinal administration of MK- 801 and NBQX demonstrates NMDA-independent dorsal horn sensitization in incisional pain // Pain. - 2005. - Vol. 114.- P.499-510.

365. Zakrzewska J.M., Patsalos P. N. Drugs used in the management of trigeminal neuralgia // Oral Surg. Oral Med. Oral Pathol. - 1992. - Vol. 74.- P.439-450.

366. Zeltser R., Beilin B., Zaslansky R., Seltzer Z. Comparison of autotomy behavior induced in rats by various clinically-used neurectomy methods // Pain. - 15- 12-2000. - Vol. 89.- P. 19-24.

367. Zha S., Yegnasubramanian V., Nelson W. G., Isaacs W. B., De Marzo A. M. Cyclooxygenases in cancer: progress and perspective // Cancer Lett. - 8-11-2004. - Vol. 215,-P.1-20.

368. Zhou L., Zhang Q., Stein C., Schafer M. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia // J. Pharmacol. Exp. Ther. - 1998. - Vol. 286.- P.1000-1006.

369.

Zhou S., Bonasera L., Carlton S. M. Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats // Neuroreport. - 22-3-1996. - Vol. 7.- P.895-900.

370. Zhou S., Komak S., Du J., Carlton S. M. Metabotropic glutamate lalpha receptors on peripheral primary afferent fibers: their role in nociception I I Brain Res. - 14-9-2001. - Vol. 913.- P.18-26.

371. Zhu C.Z., Wilson S. G., Mikusa J. P., Wismer С. T., Gauvin D. M., Lynch J. J., Ill, Wade C. L., Decker M. W., Honore P. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities // Eur. J. Pharmacol. - 15-12- 2004.-Vol. 506.-P.107-118.

372. Zhuo M., Gebhart G. F. Characterization of descending facilitation and inhibition of spinal nociceptive transmission from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat // J. Neurophysiol. - 1992. -Vol. 67.-P.1599-1614.

373. Zimmermann M. Pathobiology of neuropathic pain // Eur. J. Pharmacol. - 19- 10-2001. - Vol. 429.- P.23-37.

374. Zollinger M., Brauchli-Theotokis J., Gutteck-Amsler U., Do K. Q., Streit P., Cuenod M. Release of N-acetylaspartylglutamate from slices of rat cerebellum, striatum, and spinal cord, and the effect of climbing fiber deprivation // J. Neurochem. - 1994. - Vol. 63.- P.1133-1142.

<< |
Источник: МАЛЫШКИН Андрей Анатольевич. РОЛЬ ГЛУТАМАТЕРГИЧЕСКОЙ СИСТЕМЫ В ПРОЦЕССАХ ОСТРОЙ И ХРОНИЧЕСКОЙ БОЛИ. ДИССЕРТАЦИЯ на соискание ученой степени кандидата медицинских наук. Санкт-Петербург 2006. 2006

Скачать оригинал источника

Еще по теме СПИСОК ЛИТЕРАТУРЫ:

  1. Список рекомендуемой литературы Основная литература
  2. Список рекомендуемой литературы и веб-сайты
  3. Список литературы и материалов
  4. Список литературы
  5. Список литературы
  6. Список литературы
  7. Список литературы
  8. Список литературы
  9. Список литературы
  10. Список литературы.
  11. Список литературы
  12. Список литературы
  13. Список литературы
  14. Список литературы
  15. Список литературы
  16. Список литературы
  17. Список литературы
  18. Список литературы:
  19. Список литературы:
  20. Список литературы:
- Акушерство и гинекология - Анатомия - Андрология - Биология - Болезни уха, горла и носа - Валеология - Ветеринария - Внутренние болезни - Военно-полевая медицина - Восстановительная медицина - Гастроэнтерология и гепатология - Гематология - Геронтология, гериатрия - Гигиена и санэпидконтроль - Дерматология - Диетология - Здравоохранение - Иммунология и аллергология - Интенсивная терапия, анестезиология и реанимация - Инфекционные заболевания - Информационные технологии в медицине - История медицины - Кардиология - Клинические методы диагностики - Кожные и венерические болезни - Комплементарная медицина - Лучевая диагностика, лучевая терапия - Маммология - Медицина катастроф - Медицинская паразитология - Медицинская этика - Медицинские приборы - Медицинское право - Наследственные болезни - Неврология и нейрохирургия - Нефрология - Онкология - Организация системы здравоохранения - Оториноларингология - Офтальмология - Патофизиология - Педиатрия - Приборы медицинского назначения - Психиатрия - Психология - Пульмонология - Стоматология - Судебная медицина - Токсикология - Травматология - Фармакология и фармацевтика - Физиология - Фтизиатрия - Хирургия - Эмбриология и гистология - Эпидемиология -